Amphstar Pharmaceuticals, Inc. Income Statement
AMPH / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
Amphstar Pharmaceuticals, Inc. reported $720M in revenue and $98M in net income for FY2025. Revenue has grown at a 10.2% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $719.9M | $732.0M | $644.4M | $499.0M | $437.8M | $349.8M | $322.4M | $294.7M | $240.2M | $255.2M | $251.5M | $210.5M | $229.7M | $204.3M |
| Cost of Revenue | $363.8M | $358.1M | $293.3M | $250.1M | $238.0M | $206.5M | $190.4M | $187.7M | $149.7M | $151.0M | $174.2M | $159.2M | $142.7M | $114.0M |
| Gross Profit | $356.1M | $373.9M | $351.1M | $248.9M | $199.7M | $143.3M | $131.9M | $107.0M | $90.5M | $104.2M | $77.3M | $51.3M | $87.0M | $90.3M |
| SG&A Expense | $85.9M | $56.7M | $51.5M | $45.1M | $51.4M | $50.4M | $50.3M | $49.9M | $44.5M | $41.8M | $41.5M | $34.8M | $31.0M | $27.2M |
| R&D Expense | $85.8M | $73.9M | $73.7M | $74.8M | $60.9M | $67.2M | $68.9M | $57.6M | $43.5M | $41.5M | $37.3M | $28.9M | $33.0M | $31.2M |
| Operating Income | $140.4M | $205.4M | $197.0M | $107.5M | $69.9M | $11.0M | -$39.0K | -$8.6M | -$1.3M | $15.4M | -$6.9M | -$18.0M | $17.5M | $25.4M |
| Interest Expense | - | - | $27.2M | $1.8M | $885.0K | $374.0K | $119.0K | $243.0K | $826.0K | $1.0M | $987.0K | $609.0K | $958.0K | $784.0K |
| Income Tax | $25.5M | $29.7M | $31.8M | $23.5M | $20.6M | $3.5M | $13.7M | -$3.3M | -$2.4M | $4.8M | -$7.6M | -$7.4M | $5.4M | $7.8M |
| Net Income | $98.1M | $159.5M | $137.5M | $91.4M | $62.1M | $1.4M | $48.9M | -$5.7M | $3.6M | $9.8M | -$2.8M | -$10.7M | $11.9M | $18.1M |
| EPS (Basic) | $2.85 | $1.88 | $1.30 | $0.03 | $1.04 | -$0.12 | $0.08 | $0.22 | -$0.06 | -$0.25 | $0.31 | $0.47 | $0.31 | $0.47 |
| EPS (Diluted) | $2.60 | $1.74 | $1.25 | $0.03 | $0.98 | -$0.12 | $0.08 | $0.21 | -$0.06 | -$0.25 | $0.31 | $0.46 | $0.31 | $0.46 |
| Shares Outstanding | 47.6M | 48.1M | 48.1M | 47.7M | 47.5M | 46.6M | 46.6M | 46.6M | 46.2M | 45.2M | 44.6M | 38.8M | 38.9M | 38.9M |
| Gross Margin | 49.5% | 51.1% | 54.5% | 49.9% | 45.6% | 41.0% | 40.9% | 36.3% | 37.7% | 40.8% | 30.8% | 24.3% | 37.9% | 44.2% |
| Operating Margin | 19.5% | 28.1% | 30.6% | 21.5% | 16.0% | 3.1% | -0.0% | -2.9% | -0.5% | 6.0% | -2.7% | -8.5% | 7.6% | 12.4% |
| Profit Margin | 13.6% | 21.8% | 21.3% | 18.3% | 14.2% | 0.4% | 15.2% | -1.9% | 1.5% | 3.9% | -1.1% | -5.1% | 5.2% | 8.9% |